Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,618 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Regulatory Filings Classification · 85% confidence The document is a brief notification sent to stock exchanges under SEBI Regulation 30, providing the schedule of an analyst/institutional investor meeting. It does not contain financial statements, detailed presentations, or voting results, nor is it a publication of a report itself. It is a routine regulatory disclosure to exchanges. The best fit under the provided taxonomy is the general Regulatory Filings category (RNS).
2026-05-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a short formal disclosure under SEBI Listing Regulations providing the schedule of an analyst/institutional investor meeting with no financial data or presentation materials. It is not a financial report, earnings release, management discussion, or any other specific filing type. It falls into the miscellaneous regulatory announcements category.
2026-05-28 English
Please find enclosed Newspaper advertisement titled "Notice of 90th AGM to be held through Video Conferencing, Record Date and Final Dividend
Regulatory Filings Classification · 75% confidence The primary document is a SEBI (Listing Obligations and Disclosure Requirements) Regulation 30 disclosure letter from Cipla enclosing a newspaper advertisement giving notice of its 90th Annual General Meeting, record date and final dividend. It is not the AGM presentation itself, nor an actual financial report (10-K, IR, etc.), nor a results announcement or proxy statement. It is a general regulatory announcement pursuant to listing rules. The taxonomy does not include a specific “Notice of AGM” code, so the correct classification is the fallback Regulatory Filings category (RNS).
2026-05-21 English
Copy of Newspaper Publication
Regulatory Filings Classification · 80% confidence The document is a compliance filing under SEBI LODR Regulation 30, announcing and enclosing a newspaper advertisement for the 90th AGM notice, record date and final dividend. It is not the full AGM presentation or proxy/materials, nor is it a complete annual/quarterly report but rather a regulatory announcement to the stock exchanges. It therefore defaults to the general “Regulatory Filings” category.
2026-05-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is titled “Q4 FY26 - Earnings Call Transcript” and contains the full verbatim of Cipla’s quarterly earnings conference call including speaker introductions, forward-looking statement disclaimers, and detailed management commentary. This matches the definition of a Call Transcript (CT).
2026-05-15 English
We are enclosing hereby a copy of transcript of the Company''s Q4 FY26 earnings conference call dated 13th May, 2026
Call Transcript Classification · 95% confidence The document is the full transcript of Cipla’s Q4 FY26 earnings conference call, as indicated by the title “Q4 FY26 - Earnings Call Transcript” and the text of a moderated call between management and investors. This clearly matches the definition for Call Transcript (Code: CT).
2026-05-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.